2017
DOI: 10.1016/j.cct.2017.08.016
|View full text |Cite
|
Sign up to set email alerts
|

Pediatric advance care planning (pACP) for teens with cancer and their families: Design of a dyadic, longitudinal RCCT

Abstract: Cancer is the leading cause of disease-related death for adolescents and young adults (AYAs) in the United States. Parents of AYAs with life-threatening illnesses have expressed the desire to talk to their children about end of life (EOL) care, yet, like caregivers of adult patients, struggle to initiate this conversation. Building Evidence for Effective Palliative/End of Life Care for Teens with Cancer is a longitudinal, randomized, controlled, single-blinded clinical trial aimed at evaluating the efficacy of… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
45
0
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
5

Relationship

5
0

Authors

Journals

citations
Cited by 22 publications
(48 citation statements)
references
References 47 publications
0
45
0
1
Order By: Relevance
“…Recruitment, consent/assent, and completion of baseline data questionnaires have been described in the published protocol. 21…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Recruitment, consent/assent, and completion of baseline data questionnaires have been described in the published protocol. 21…”
Section: Methodsmentioning
confidence: 99%
“…Recruitment, consent/assent, and completion of baseline data questionnaires have been described in the published protocol 21 . Session 2 of the three‐session FAmily CEntered pediatric ACP intervention for teens with cancer (FACE‐TC) consisted of the Respecting Choices Advance Care Planning: Next Steps interview 19 .…”
Section: Methodsmentioning
confidence: 99%
“…Enrollment was from July 16, 2016 through April 30, 2019. Methods of this study and the protocol have been published elsewhere 8 . Eligibility criteria for adolescents were ≥14 and <21 years old at the time of enrollment, have a cancer diagnosis, English speaking, and without developmental delays.…”
Section: Methodsmentioning
confidence: 99%
“…Participants with cancer ages 18 years up to 21 years provided informed written consent. All participants under the age of 18 provided written informed assent with parent or guardian consent as well 8 . A Safety Monitoring Committee monitored the protocol yearly.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation